{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["15(1)"],"submitter":["Luther K"],"pubmed_abstract":["Engineering of human ARRDC1-mediated microvesicles (ARMMs) as non-viral vehicles for delivery of gene therapies bears the potential to enable novel therapeutic paradigms. We evaluated two scalable strategies to generate ARMMs loaded with protein cargo, by transient transfection or stable cell line-based production. The upstream ARMMs production processes utilized a suspension-adapted HEK293-derived line, termed 5B8. 5B8 cells yielded robust production of ARMMs after transient transfection with the ARMMs loading construct or using a stable cell line containing a transgene that encodes the ARMMs loading cassette, in shake flasks or a stirred tank bioreactor, respectively. ARMMs were purified by ultracentrifugation (small scale) or a combination of TFF and AEX (scalable production). Both puri"],"journal":["Scientific reports"],"pagination":["7299"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11873033"],"repository":["biostudies-literature"],"pubmed_title":["Scalable production and purification of engineered ARRDC1-mediated microvesicles in a HEK293 suspension cell system."],"pmcid":["PMC11873033"],"pubmed_authors":["Zocco D","Gens L","Semple C","Ramaswamy S","Passalacqua I","Liu SL","Sun L","Wang Q","Moharil P","Vyas K","Luther K","Navaei A","Nabhan JF"],"additional_accession":[]},"is_claimable":false,"name":"Scalable production and purification of engineered ARRDC1-mediated microvesicles in a HEK293 suspension cell system.","description":"Engineering of human ARRDC1-mediated microvesicles (ARMMs) as non-viral vehicles for delivery of gene therapies bears the potential to enable novel therapeutic paradigms. We evaluated two scalable strategies to generate ARMMs loaded with protein cargo, by transient transfection or stable cell line-based production. The upstream ARMMs production processes utilized a suspension-adapted HEK293-derived line, termed 5B8. 5B8 cells yielded robust production of ARMMs after transient transfection with the ARMMs loading construct or using a stable cell line containing a transgene that encodes the ARMMs loading cassette, in shake flasks or a stirred tank bioreactor, respectively. ARMMs were purified by ultracentrifugation (small scale) or a combination of TFF and AEX (scalable production). Both puri","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Mar","modification":"2025-04-22T20:07:21.455Z","creation":"2025-04-06T03:02:01.782Z"},"accession":"S-EPMC11873033","cross_references":{"pubmed":["40025043"],"doi":["10.1038/s41598-025-87674-5"]}}